Cancer Family
Malignant Digestive System Neoplasm
CI-CAN-00000229Explore in graph →
4,262 active trials43 approved drugs556 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000229Explore in graph →
Clinical trials
19,108 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (2,001)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01477190 | Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program | completed | Phase 1 / Phase 2 | 40 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Nov 28, 2011 | clinicaltrials |
| NCT00866944 | Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases(MT201-204) | completed | Phase 2 | 35 | Amgen Research (Munich) GmbHINDUSTRY |
| 2 |
| Nov 11, 2011 |
| clinicaltrials |
| NCT00354978 | Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | completed | Phase 2 | 49 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT01070355 | Eicosapentaenoic Acid (EPA) for Treatment of Colorectal Cancer Liver Metastases(EMT) | completed | Phase 2 | 88 | University of LeedsOTHER | 1 | Oct 21, 2011 | clinicaltrials |
| NCT00519688 | UFUR Plus Thalidomide for Advanced Hepatocellular Carcinoma | completed | Phase 2 | 44 | National Taiwan University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00250822 | Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter | completed | Phase 2 | 11 | New Mexico Cancer Research AllianceOTHER | 1 | Oct 5, 2011 | clinicaltrials |
| NCT01253837 | L19TNFα in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 34 | Philogen S.p.A.INDUSTRY | 1 | Sep 23, 2011 | clinicaltrials |
| NCT00703365 | Efficacy and Safety of Sorafenib (Nexavar) in Combination With Gemcitabine in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 45 | Mahidol UniversityOTHER | 1 | Aug 29, 2011 | clinicaltrials |
| NCT00345696 | 1stline Study Capecitabine Administered on Continuous Way Plus Oxaliplatin&Bevacizumab Every 2weeks in Metastatic CCR. | completed | Phase 2 | 32 | Unidad Integral de Investigación en Oncología S.L.OTHER | 1 | Aug 24, 2011 | clinicaltrials |
| NCT00073736 | Safety and Tolerability of I.V. Infusion of MB07133 in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 28 | Ligand PharmaceuticalsINDUSTRY | 3 | Aug 12, 2011 | clinicaltrials |
| NCT00568646 | Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | 33 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00004233 | S9915 Triacetyluridine, Fluorouracil, and Leucovorin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Cancer of the Esophagus or Stomach | completed | Phase 2 | 65 | SWOG Cancer Research NetworkNETWORK | 1 | Jul 25, 2011 | clinicaltrials |
| NCT01396668 | Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 35 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01396681 | Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer | completed | Phase 2 | 70 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00287222 | Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma | completed | Phase 2 | 21 | University of ArkansasOTHER | 1 | Jul 15, 2011 | clinicaltrials |
| NCT00882869 | XIAP Antisense AEG35156 in Combination With Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 75 | Aegera TherapeuticsINDUSTRY | 1 | Jul 13, 2011 | clinicaltrials |
| NCT00970138 | Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 / Phase 3 | 141 | Fudan UniversityOTHER | 1 | Jul 12, 2011 | clinicaltrials |
| NCT00910572 | Radioembolization With Yttrium-90 Microspheres for Intermediate or Advanced Hepatocellular Carcinoma | completed | Phase 2 | 60 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Jul 1, 2011 | clinicaltrials |
| NCT00287755 | Clinical Trial of Chemosensitivity Test | completed | Phase 2 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00497263 | End-to-End Compression Anastomosis for Left-sided Colectomy Endo-CAR Study | completed | Phase 2 | — | Niti Medical Technologies Ltd.INDUSTRY | 1 | Jun 29, 2011 | clinicaltrials |
| NCT00514163 | GEM vs GEM+TS-1 for Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00559455 | Phase II Study of Eloxatin+5-FU/LV in Patients With Unresectable Hepatocellular Carcinoma | completed | Phase 2 | 38 | SanofiINDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00595972 | Epirubicin Cisplatin and Fluorouracil (FU) Combined With Endostar in Patients With Advanced or Metastatic Gastric Cancer | completed | Phase 2 | 25 | Fudan UniversityOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00639327 | Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer | completed | Phase 2 / Phase 3 | 300 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00809796 | A Safety Study of Pentamidine in Patients With Metastatic Colon Cancer Undergoing Standard Chemotherapy as Second-line and/or Third-line Treatment | completed | Phase 1 / Phase 2 | 15 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00810953 | A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy | completed | Phase 1 / Phase 2 | 10 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00004087 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00504998 | Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00291785 | Phase I/II CT 2106 and 5-FU/FA in Colorectal Cancer | completed | Phase 1 / Phase 2 | 48 | CTI BioPharmaINDUSTRY | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00827684 | Temsirolimus and Irinotecan for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations(TIRASMUS) | completed | Phase 2 | 50 | Vejle HospitalOTHER | 1 | Jun 8, 2011 | clinicaltrials |
| NCT00544349 | Leucovorin, Fluorouracil, Cetuximab, and Oxaliplatin in Treating Patients With Stage IV Colorectal Cancer and Liver Metastases That Cannot Be Removed by Surgery | completed | Phase 2 | 45 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 17, 2011 | clinicaltrials |
| NCT00559741 | Cetuximab and Combination Chemotherapy in Treating Patients With Advanced or Metastatic Colorectal Cancer | completed | Phase 2 | 80 | Institut Cancerologie de l'OuestOTHER | 1 | May 13, 2011 | clinicaltrials |
| NCT00002506 | Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer | completed | Phase 2 | — | Hoag Memorial Hospital PresbyterianOTHER | 1 | May 12, 2011 | clinicaltrials |
| NCT00051480 | Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer | completed | Phase 2 | — | GenVecINDUSTRY | 1 | May 12, 2011 | clinicaltrials |
| NCT00193167 | Weekly Topotecan in Patients Treated for Metastatic Colorectal Cancer | completed | Phase 2 | 40 | SCRI Development Innovations, LLCOTHER | 1 | May 3, 2011 | clinicaltrials |
| NCT01338948 | Image-guided Minimally Invasive Robotic Surgery Using Preoperative CT Scan for Gastric Cancer Patients | completed | Phase 1 / Phase 2 | 12 | Yonsei UniversityOTHER | 1 | Apr 20, 2011 | clinicaltrials |
| NCT00004103 | Combination Chemotherapy Followed by Surgery in Treating Patients With Stomach Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00005049 | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer | completed | Phase 2 | 45 | NYU Langone HealthOTHER | 1 | Apr 6, 2011 | clinicaltrials |
| NCT00578201 | FOLFOX-Cetuximab-radiotherapy for the Treatment of Esophageal Cancer(FOLFOX) | completed | Phase 2 | 80 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Mar 31, 2011 | clinicaltrials |
| NCT00003332 | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer | completed | Phase 1 / Phase 2 | 36 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00004102 | Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer | completed | Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00005050 | Eniluracil, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Colorectal Cancer | completed | Phase 1 / Phase 2 | — | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00832689 | Irinotecan, Gemcitabine, Chemotherapy for Biliary Tract Cancer | completed | Phase 2 | 39 | Yonsei UniversityOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00060268 | Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors | completed | Phase 1 / Phase 2 | 11 | Roswell Park Cancer InstituteOTHER | 1 | Mar 9, 2011 | clinicaltrials |
| NCT00004248 | Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 24 | Roswell Park Cancer InstituteOTHER | 1 | Mar 7, 2011 | clinicaltrials |
| NCT00118755 | A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | 435 | Hoffmann-La RocheINDUSTRY | 0 | Mar 3, 2011 | clinicaltrials |
| NCT00815308 | Erbitux Combined With Chemo-radiotherapy in Esophageal Squamous Cell Carcinoma(EXCEL) | completed | Phase 2 | 55 | Shandong Cancer Hospital and InstituteOTHER | 1 | Feb 8, 2011 | clinicaltrials |
| NCT00192075 | A Randomized Trial of Avastin + Gemcitabine + 5-Fluorouracil (5FU)/Folinic Acid Versus Avastin + Oxaliplatin + 5FU/Folinic Acid in Metastatic Colorectal Cancer | completed | Phase 2 | 84 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 7, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Nov 28, 2011source: clinicaltrials